Breaking News

Mission Bio, AGBL Group Partner on Tapestri Platform for CGTs

New capabilities for Tapestri Platform aim to support faster, more reliable characterization of cell and gene therapy product.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has signed an agreement with Alliance Global (AGBL Group), distributors of biomedical technology and products. The agreement will allow Mission Bio to expand its product offerings into the Middle East and Africa, two key regions for Mission Bio’s growth strategy as it expands a global reach.   The partnership builds on Mission Bio’s goal to provide high-quality single-cell multi-omics with the Tap...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters